Immunome Inc. (IMNM)
10.12
0.74 (7.89%)
At close: Jan 15, 2025, 3:59 PM
10.11
-0.05%
After-hours Jan 15, 2025, 04:33 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -1.99 | -0.71 | -6.11 | -5.72 | -7.32 | -1.87 |
| PS Ratio | 15.15 | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 1.77 | 1.61 | 3.10 | 2.37 | -2.17 | -0.58 |
| P/FCF Ratio | -25.28 | -0.93 | -8.17 | -7.69 | -7.86 | -1.92 |
| P/OCF Ratio | -28.06 | -0.93 | -8.2 | -8.07 | -8.05 | -1.98 |
| OCF/S Ratio | -0.54 | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.01 | -0.02 | -0.05 |
| Quick Ratio | 6.63 | 3.21 | 6.27 | 14.42 | 1.88 | 1.35 |
| Current Ratio | 6.63 | 3.09 | 5.82 | 14.12 | 1.88 | 1.35 |
| Asset Turnover | 0.09 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | -7.38K | -2.52K | -322.66 | -97.62 | -54.91 |
| Return on Equity (ROE) | -0.89 | -2.25 | -0.51 | -0.41 | 0.30 | 0.31 |
| Return on Assets (ROA) | -0.72 | -1.56 | -0.42 | -0.38 | -2.08 | -1.76 |
| Return on Capital (ROIC) | -0.86 | -2.21 | -0.52 | -0.3 | -3.05 | -2.68 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -63.54% | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -761.92% | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -761.92% | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -781.35% | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -59.92% | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -201.68% | n/a | n/a | n/a | n/a | n/a |